Determination of l-alpha-acetylmethadol, l-alpha-noracetylmethadol and l-alpha-dinoracetylmethadol in plasma by gas chromatography-mass spectrometry.

Journal Article (Journal Article)

A method is described for the simultaneous determination of l-alpha-acetylmethadol (LAAM) and its N-demethylated metabolites, l-alpha-noracetylmethadol (norLAAM) and l-alpha-dinoracetylmethadol (dinorLAAM), in plasma by gas chromatography-chemical ionization mass spectrometry. Deuterated internal standards for each analyte serve as carriers and control for recovery during sample purification on a solid-phase extraction column (C18), and subsequent separation and analysis on a DB-17 capillary column. With this method, we have determined levels of LAAM, norLAAM, and dinorLAAM in small volumes of plasma (100 microliters). The limit of quantitation for all analytes was approximately 1.0 ng/g plasma and the limit of detection was approximately 0.5 ng/g plasma. An experimental application is also described where these analytes are quantitated in plasma obtained from rats before, during, and after chronic administration of LAAM-HCl. Since this technique affords a selective and sensitive means of detection of LAAM and its active, N-demethylated metabolites in small samples of blood, it may enable patient compliance to be more easily assessed by allowing samples to be collected by a simple finger-prick technique.

Full Text

Duke Authors

Cited Authors

  • Thomas, BF; Jeffcoat, AR; Myers, MW; Mathews, JM; Cook, CE

Published Date

  • May 13, 1994

Published In

Volume / Issue

  • 655 / 2

Start / End Page

  • 201 - 211

PubMed ID

  • 8081466

International Standard Serial Number (ISSN)

  • 1572-6495

Digital Object Identifier (DOI)

  • 10.1016/0378-4347(94)00097-2


  • eng

Conference Location

  • Netherlands